Latest News and Press Releases

New York, USA, April 22, 2025 (GLOBE NEWSWIRE) -- Parkinson’s Disease Therapeutic Domain Projected to See Transformational Growth Across the 7MM During the Study Period (2020–2034) | DelveInsight ...

AGOURA HILLS, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications,...

SPARK NS announces the eight projects selected to receive aggregate funding of up to $16 million to advance academic discoveries in Parkinson’s disease

Parkinson's disease reversed for 200 human medical research patients

Washington, D.C., March 05, 2025 (GLOBE NEWSWIRE) -- The Aligning Science Across Parkinson’s (ASAP) initiative opened applications for members of the research community to accelerate novel tool...

Groundbreaking fMRI study that showed a 21.2% increase in brain blood flow in a Parkinson’s patient after six months of intranasal FGF1 therapy.

New York, USA, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight Alpha-synuclein...

Tampa, Fla., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Axiom Brain Health (Axiom) and the Global Alzheimer’s Platform Foundation® (GAP) celebrated the next chapter in neurodegenerative research at the...

Washington, D.C., Jan. 15, 2025 (GLOBE NEWSWIRE) -- The Aligning Science Across Parkinson’s (ASAP) initiative opened applications for members of the research community to apply to join the...

New York, USA, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Parkinson's Disease Market is Expected to Showcase a Significant Growth at a CAGR of 5.8% During the Study Period (2020–2034) | DelveInsight  The...